Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1988 1
1993 3
1996 1
1998 2
1999 3
2000 1
2001 2
2002 1
2003 2
2004 3
2005 2
2007 1
2008 4
2009 1
2012 1
2013 2
2014 1
2016 1
2017 1
2019 2
2020 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Myoclonus.
Rivest J. Rivest J. Can J Neurol Sci. 2003 Mar;30 Suppl 1:S53-8. doi: 10.1017/s0317167100003243. Can J Neurol Sci. 2003. PMID: 12691477 Review.
The source of myoclonus may be in the cerebral cortex, the brain stem or the spinal cord and multiple generators may be involved in a single patient. The clinical approach to myoclonus relies on both etiological and physiological classifications. ...Polytherapy may be requ …
The source of myoclonus may be in the cerebral cortex, the brain stem or the spinal cord and multiple generators may be involved in a single …
Physiology-Based Treatment of Myoclonus.
Pena AB, Caviness JN. Pena AB, et al. Neurotherapeutics. 2020 Oct;17(4):1665-1680. doi: 10.1007/s13311-020-00922-6. Neurotherapeutics. 2020. PMID: 32910414 Free PMC article. Review.
Myoclonus has a strikingly diverse array of underlying etiologies, clinical presentations, and pathophysiological mechanisms. Treatment of myoclonus is vital to improving the quality of life of patients with these disorders. ...Levetiracetam, valproic acid, and clonazepam …
Myoclonus has a strikingly diverse array of underlying etiologies, clinical presentations, and pathophysiological mechanisms. Treatme …
Myoclonus.
Espay AJ, Chen R. Espay AJ, et al. Continuum (Minneap Minn). 2013 Oct;19(5 Movement Disorders):1264-86. doi: 10.1212/01.CON.0000436156.54532.1a. Continuum (Minneap Minn). 2013. PMID: 24092290 Review.
The entity previously known as palatal myoclonus has been reclassified as palatal tremor in recognition of its clinical and electromyographic features and no longer enters the differential diagnosis of myoclonic disorders. ...Electrophysiologic testing aids in distinguishi …
The entity previously known as palatal myoclonus has been reclassified as palatal tremor in recognition of its clinical and electromy …
Treatment of myoclonus.
Caviness JN. Caviness JN. Neurotherapeutics. 2014 Jan;11(1):188-200. doi: 10.1007/s13311-013-0216-3. Neurotherapeutics. 2014. PMID: 24037428 Free PMC article. Review.
The best etiological classification scheme is a modified version from that proposed by Marsden et al. in 1982. Clinical neurophysiology, as assessed by electromyography and electroencephalography, can be used to classify the pathophysiology of the myoclonus using a neuroph …
The best etiological classification scheme is a modified version from that proposed by Marsden et al. in 1982. Clinical neurophysiolo …
Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis.
Corniello C, Dono F, Evangelista G, Consoli S, De Angelis S, Cipollone S, Liviello D, Polito G, Melchiorre S, Russo M, Granzotto A, Anzellotti F, Onofrj M, Thomas A, Sensi SL. Corniello C, et al. Seizure. 2023 Jul;109:62-67. doi: 10.1016/j.seizure.2023.05.017. Epub 2023 May 21. Seizure. 2023. PMID: 37267668 Free article. Review.
INTRODUCTION: The late onset myoclonic epilepsy in Down Syndrome (LOMEDS) is a peculiar epilepsy type characterized by cortical myoclonus and generalized tonic-clonic seizures (GTCS), in people suffering from cognitive decline in Down syndrome (DS). ...RESULTS: Data …
INTRODUCTION: The late onset myoclonic epilepsy in Down Syndrome (LOMEDS) is a peculiar epilepsy type characterized by cortical my …
Amantadine-induced cortical myoclonus.
Matsunaga K, Uozumi T, Qingrui L, Hashimoto T, Tsuji S. Matsunaga K, et al. Neurology. 2001 Jan 23;56(2):279-80. doi: 10.1212/wnl.56.2.279. Neurology. 2001. PMID: 11160978 No abstract available.
Piracetam in the treatment of cortical myoclonus.
Genton P, Guerrini R, Remy C. Genton P, et al. Pharmacopsychiatry. 1999 Mar;32 Suppl 1:49-53. doi: 10.1055/s-2007-979237. Pharmacopsychiatry. 1999. PMID: 10338109 Review.
This paper reviews existing publications on the use of piracetam for the treatment of cortical myoclonus of various etiologies and includes the personal experience of the authors in progressive myoclonus epilepsy. ...Piracetam should be considered a first-line drug …
This paper reviews existing publications on the use of piracetam for the treatment of cortical myoclonus of various etiologies …
Coherent cortical and muscle discharge in cortical myoclonus.
Brown P, Farmer SF, Halliday DM, Marsden J, Rosenberg JR. Brown P, et al. Brain. 1999 Mar;122 ( Pt 3):461-72. doi: 10.1093/brain/122.3.461. Brain. 1999. PMID: 10094255
This oscillatory drive may be exaggerated in patients with cortical myoclonus. Spectral analysis of surface bipolar EEG and EMG activity was performed in eight such patients. ...The results provide clear evidence of a cortical drive synchronizing muscle discharge ov …
This oscillatory drive may be exaggerated in patients with cortical myoclonus. Spectral analysis of surface bipolar EEG and EM …
Low-dose perampanel improves refractory cortical myoclonus by the dispersed and suppressed paroxysmal depolarization shifts in the sensorimotor cortex.
Oi K, Neshige S, Hitomi T, Kobayashi K, Tojima M, Matsuhashi M, Shimotake A, Fujii D, Matsumoto R, Kasama S, Kanda M, Wada Y, Maruyama H, Takahashi R, Ikeda A. Oi K, et al. Clin Neurophysiol. 2019 Oct;130(10):1804-1812. doi: 10.1016/j.clinph.2019.07.006. Epub 2019 Jul 19. Clin Neurophysiol. 2019. PMID: 31401489
OBJECTIVE: To elucidate the effects of perampanel (PER) on refractory cortical myoclonus for dose, etiology and somatosensory-evoked potential (SEP) findings. ...CONCLUSIONS: Low-dose PER markedly improved myoclonus and ADL in patients with refractory cortical …
OBJECTIVE: To elucidate the effects of perampanel (PER) on refractory cortical myoclonus for dose, etiology and somatosensory- …
40 results